Logo image of AXR

AMREP CORP (AXR) Stock Fundamental Analysis

NYSE:AXR - New York Stock Exchange, Inc. - US0321591051 - Common Stock - Currency: USD

21.56  +0.25 (+1.17%)

Fundamental Rating

8

AXR gets a fundamental rating of 8 out of 10. The analysis compared the fundamentals against 65 industry peers in the Real Estate Management & Development industry. Both the health and profitability get an excellent rating, making AXR a very profitable company, without any liquidiy or solvency issues. AXR is not overvalued while it is showing excellent growth. This is an interesting combination. This makes AXR very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

AXR had positive earnings in the past year.
AXR had a positive operating cash flow in the past year.
Of the past 5 years AXR 4 years were profitable.
AXR had a positive operating cash flow in each of the past 5 years.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

The Return On Assets of AXR (10.06%) is better than 96.92% of its industry peers.
With an excellent Return On Equity value of 10.29%, AXR belongs to the best of the industry, outperforming 87.69% of the companies in the same industry.
The Return On Invested Capital of AXR (8.35%) is better than 95.38% of its industry peers.
AXR had an Average Return On Invested Capital over the past 3 years of 11.51%. This is significantly above the industry average of 5.55%.
Industry RankSector Rank
ROA 10.06%
ROE 10.29%
ROIC 8.35%
ROA(3y)13.67%
ROA(5y)8.5%
ROE(3y)14.81%
ROE(5y)9.15%
ROIC(3y)11.51%
ROIC(5y)N/A
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

AXR has a better Profit Margin (22.34%) than 93.85% of its industry peers.
In the last couple of years the Profit Margin of AXR has grown nicely.
AXR has a better Operating Margin (22.81%) than 87.69% of its industry peers.
In the last couple of years the Operating Margin of AXR has declined.
With a decent Gross Margin value of 35.18%, AXR is doing good in the industry, outperforming 64.62% of the companies in the same industry.
AXR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 22.81%
PM (TTM) 22.34%
GM 35.18%
OM growth 3Y-12.96%
OM growth 5YN/A
PM growth 3Y-10.97%
PM growth 5Y2.13%
GM growth 3Y-7.98%
GM growth 5Y29.24%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AXR is creating some value.
The number of shares outstanding for AXR has been reduced compared to 1 year ago.
Compared to 5 years ago, AXR has less shares outstanding
The debt/assets ratio for AXR is higher compared to a year ago.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

AXR has an Altman-Z score of 25.55. This indicates that AXR is financially healthy and has little risk of bankruptcy at the moment.
AXR's Altman-Z score of 25.55 is amongst the best of the industry. AXR outperforms 96.92% of its industry peers.
The Debt to FCF ratio of AXR is 0.00, which is an excellent value as it means it would take AXR, only 0.00 years of fcf income to pay off all of its debts.
AXR has a better Debt to FCF ratio (0.00) than 92.31% of its industry peers.
AXR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
AXR has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. AXR outperforms 87.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 25.55
ROIC/WACC0.91
WACC9.15%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.3 Liquidity

AXR has a Current Ratio of 34.79. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
AXR has a Current ratio of 34.79. This is amongst the best in the industry. AXR outperforms 98.46% of its industry peers.
A Quick Ratio of 12.59 indicates that AXR has no problem at all paying its short term obligations.
AXR has a Quick ratio of 12.59. This is amongst the best in the industry. AXR outperforms 96.92% of its industry peers.
Industry RankSector Rank
Current Ratio 34.79
Quick Ratio 12.59
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

9

3. Growth

3.1 Past

AXR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 475.10%, which is quite impressive.
AXR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 47.37% yearly.
The Revenue has grown by 30.36% in the past year. This is a very strong growth!
AXR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.04% yearly.
EPS 1Y (TTM)475.1%
EPS 3Y9.61%
EPS 5Y47.37%
EPS Q2Q%566.5%
Revenue 1Y (TTM)30.36%
Revenue growth 3Y8.61%
Revenue growth 5Y32.04%
Sales Q2Q%-40.74%

3.2 Future

AXR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.07% yearly.
The Revenue is expected to grow by 332.72% on average over the next years. This is a very strong growth
EPS Next YN/A
EPS Next 2Y17.49%
EPS Next 3Y15.53%
EPS Next 5Y16.07%
Revenue Next YearN/A
Revenue Next 2Y3367.11%
Revenue Next 3Y991.44%
Revenue Next 5Y332.72%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 2028 2029 20B 40B 60B
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.91, which indicates a very decent valuation of AXR.
AXR's Price/Earnings ratio is rather cheap when compared to the industry. AXR is cheaper than 89.23% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.53. AXR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.91
Fwd PE N/A
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

98.46% of the companies in the same industry are more expensive than AXR, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AXR is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.97
EV/EBITDA 5.65
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The excellent profitability rating of AXR may justify a higher PE ratio.
A more expensive valuation may be justified as AXR's earnings are expected to grow with 15.53% in the coming years.
PEG (NY)N/A
PEG (5Y)0.19
EPS Next 2Y17.49%
EPS Next 3Y15.53%

0

5. Dividend

5.1 Amount

No dividends for AXR!.
Industry RankSector Rank
Dividend Yield N/A

AMREP CORP

NYSE:AXR (6/9/2025, 8:10:48 PM)

21.56

+0.25 (+1.17%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-17 2025-03-17
Earnings (Next)07-21 2025-07-21
Inst Owners42.34%
Inst Owner Change2.96%
Ins Owners44.9%
Ins Owner Change0%
Market Cap114.05M
Analysts0
Price TargetN/A
Short Float %1.41%
Short Ratio2.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.91
Fwd PE N/A
P/S 1.96
P/FCF 7.97
P/OCF 7.81
P/B 0.91
P/tB 0.91
EV/EBITDA 5.65
EPS(TTM)2.42
EY11.22%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.71
FCFY12.55%
OCF(TTM)2.76
OCFY12.81%
SpS10.97
BVpS23.81
TBVpS23.81
PEG (NY)N/A
PEG (5Y)0.19
Profitability
Industry RankSector Rank
ROA 10.06%
ROE 10.29%
ROCE 10.51%
ROIC 8.35%
ROICexc 11.81%
ROICexgc 11.87%
OM 22.81%
PM (TTM) 22.34%
GM 35.18%
FCFM 24.66%
ROA(3y)13.67%
ROA(5y)8.5%
ROE(3y)14.81%
ROE(5y)9.15%
ROIC(3y)11.51%
ROIC(5y)N/A
ROICexc(3y)14.28%
ROICexc(5y)N/A
ROICexgc(3y)14.32%
ROICexgc(5y)N/A
ROCE(3y)14.5%
ROCE(5y)N/A
ROICexcg growth 3Y-13.41%
ROICexcg growth 5YN/A
ROICexc growth 3Y-13.43%
ROICexc growth 5YN/A
OM growth 3Y-12.96%
OM growth 5YN/A
PM growth 3Y-10.97%
PM growth 5Y2.13%
GM growth 3Y-7.98%
GM growth 5Y29.24%
F-Score8
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 169.77%
Cap/Sales 0.5%
Interest Coverage 250
Cash Conversion 108.87%
Profit Quality 110.39%
Current Ratio 34.79
Quick Ratio 12.59
Altman-Z 25.55
F-Score8
WACC9.15%
ROIC/WACC0.91
Cap/Depr(3y)361.42%
Cap/Depr(5y)217.58%
Cap/Sales(3y)1.12%
Cap/Sales(5y)0.68%
Profit Quality(3y)90.43%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)475.1%
EPS 3Y9.61%
EPS 5Y47.37%
EPS Q2Q%566.5%
EPS Next YN/A
EPS Next 2Y17.49%
EPS Next 3Y15.53%
EPS Next 5Y16.07%
Revenue 1Y (TTM)30.36%
Revenue growth 3Y8.61%
Revenue growth 5Y32.04%
Sales Q2Q%-40.74%
Revenue Next YearN/A
Revenue Next 2Y3367.11%
Revenue Next 3Y991.44%
Revenue Next 5Y332.72%
EBIT growth 1Y77.7%
EBIT growth 3Y-5.47%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y1046.89%
EBIT Next 5Y358.43%
FCF growth 1Y14.53%
FCF growth 3Y-6.63%
FCF growth 5Y77.63%
OCF growth 1Y15.46%
OCF growth 3Y-5.29%
OCF growth 5Y78.57%